Literature DB >> 26230915

Zinc finger X-chromosomal protein (ZFX) is a significant prognostic indicator and promotes cellular malignant potential in gallbladder cancer.

Hao Weng1, Xu'an Wang1, Maolan Li1, Xiangsong Wu1, Zheng Wang1, Wenguang Wu1, Zhou Zhang1, Yijian Zhang1, Shuai Zhao1, Shibo Liu1, Jiasheng Mu1, Yang Cao1, Yijun Shu1, Runfa Bao1, Jian Zhou1, Jianhua Lu1, Ping Dong1, Jun Gu1, Yingbin Liu1.   

Abstract

The Zinc finger X-chromosomal protein (ZFX), a novel member of the Krueppel C2H2-type zinc finger protein family, has been implicated in multiple human cancers. However, the clinical significance of ZFX expression in gallbladder cancer (GBC) remains largely unknown. In this study, we focused on the clinical significance, biological function and mechanism of ZFX in GBC, and found that ZFX protein overexpression was frequently detected in GBC tissues. The expression of ZFX was significantly correlated with histological grade, perineural invasion, and margin status and lead to a significantly poorer prognosis in GBC patients(P <0.001). Furthermore, knockdown of ZFX result in significant inhibition of proliferation, migration, invasion and cause cell cycle arrest in GBC-SD cells, while over-expression of ZFX in NOZ shows the opposite results. Activation of PI3K/AKT pathway maybe the potential mechanism behind these effects. In conclusion, ZFX may serve as a oncogene and could be used as a potential prognostic marker and genetic treatment target for GBC patients.

Entities:  

Keywords:  Gallbladder cancer; Immunohistochemistry; PI3K/AKT pathway; RNA interference; Zinc finger X-chromosomal protein; cell cycle regulation; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26230915      PMCID: PMC4846125          DOI: 10.1080/15384047.2015.1070994

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  25 in total

Review 1.  Outcomes in biliary malignancy.

Authors:  Bas Groot Koerkamp; Yuman Fong
Journal:  J Surg Oncol       Date:  2014-10       Impact factor: 3.454

2.  NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells.

Authors:  Zhujun Tan; Maolan Li; Wenguang Wu; Lin Zhang; Qichen Ding; Xiangsong Wu; Jiasheng Mu; Yingbin Liu
Journal:  Mol Cell Biochem       Date:  2012-06-24       Impact factor: 3.396

3.  Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma.

Authors:  Kwang Hwa Jung; Jeong Kyu Kim; Ji Heon Noh; Jung Woo Eun; Hyun Jin Bae; Hong Jian Xie; Young Min Ahn; Won Sang Park; Jung Young Lee; Suk Woo Nam
Journal:  J Cell Biochem       Date:  2010-06-01       Impact factor: 4.429

4.  Knockdown of ZFX inhibits gastric cancer cell growth in vitro and in vivo via downregulating the ERK-MAPK pathway.

Authors:  Shuai Wu; Xin-Yuan Lao; Tian-Tian Sun; Lin-Lin Ren; Xuan Kong; Ji-Lin Wang; Ying-Chao Wang; Wan Du; Ya-Nan Yu; Yu-Rong Weng; Jie Hong; Jing-Yuan Fang
Journal:  Cancer Lett       Date:  2013-04-13       Impact factor: 8.679

5.  Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.

Authors:  Maolan Li; Zhou Zhang; Xiaoguang Li; Junyi Ye; Xiangsong Wu; Zhujun Tan; Chang Liu; Baiyong Shen; Xu-An Wang; Wenguang Wu; Daizhan Zhou; Di Zhang; Ting Wang; Bingya Liu; Kai Qu; Qichen Ding; Hao Weng; Qian Ding; Jiasheng Mu; Yijun Shu; Runfa Bao; Yang Cao; Peizhan Chen; Tianyu Liu; Lin Jiang; Yunping Hu; Ping Dong; Jun Gu; Wei Lu; Weibin Shi; Jianhua Lu; Wei Gong; Zhaohui Tang; Yong Zhang; Xuefeng Wang; Y Eugene Chin; Xiaoling Weng; Hong Zhang; Wei Tang; Yonglan Zheng; Lin He; Hui Wang; Yun Liu; Yingbin Liu
Journal:  Nat Genet       Date:  2014-07-06       Impact factor: 38.330

6.  Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway.

Authors:  Dong Li; Li-Nan Zhao; Xiu-Lan Zheng; Ping Lin; Feng Lin; Yue Li; Hai-Feng Zou; Rong-Jun Cui; Hui Chen; Xiao-Guang Yu
Journal:  Mol Med Rep       Date:  2014-10-13       Impact factor: 2.952

7.  Regulation of cell proliferation and migration in gallbladder cancer by zinc finger X-chromosomal protein.

Authors:  Zhujun Tan; Shenglai Zhang; Maolan Li; Xiangsong Wu; Hao Weng; Qian Ding; Yang Cao; Runfa Bao; Yijun Shu; Jiasheng Mu; Qichen Ding; Wenguang Wu; Jiahua Yang; Lin Zhang; Yingbin Liu
Journal:  Gene       Date:  2013-07-13       Impact factor: 3.688

8.  Zfx facilitates tumorigenesis caused by activation of the Hedgehog pathway.

Authors:  Colin J Palmer; Jose M Galan-Caridad; Stuart P Weisberg; Liang Lei; Jose M Esquilin; Gist F Croft; Brandon Wainwright; Peter Canoll; David M Owens; Boris Reizis
Journal:  Cancer Res       Date:  2014-08-27       Impact factor: 12.701

9.  ZFX knockdown inhibits growth and migration of non-small cell lung carcinoma cell line H1299.

Authors:  Kui Li; Zhi-Chuan Zhu; Yong-Jie Liu; Ji-Wei Liu; Hong-Tao Wang; Zhi-Qi Xiong; Xu Shen; Ze-Lan Hu; Jing Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

10.  Zinc finger X-chromosomal protein promotes growth and tumorigenesis in human osteosarcoma cells.

Authors:  Rui Jiang; Zhong-Li Gao; Mei Sun; Xing-Yi Zhang; Jin-Cheng Wang; Han Wu
Journal:  Pak J Med Sci       Date:  2013-07       Impact factor: 1.088

View more
  13 in total

1.  Identification of epigenetic modulators in human breast cancer by integrated analysis of DNA methylation and RNA-Seq data.

Authors:  Xin Zhou; Zhibin Chen; Xiaodong Cai
Journal:  Epigenetics       Date:  2018-08-07       Impact factor: 4.528

2.  MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX.

Authors:  Hongbin Bao; Xinguo Li; Hengli Li; Hongli Xing; Binghui Xu; Xianfeng Zhang; Zhaoming Liu
Journal:  J Biosci       Date:  2017-03       Impact factor: 1.826

3.  Zfx-induced upregulation of UBE2J1 facilitates endometrial cancer progression via PI3K/AKT pathway.

Authors:  Dexin Yang; Xin Ma; Jie Xu; Ke Jia; Xiaoli Liu; Ping Zhang
Journal:  Cancer Biol Ther       Date:  2021-02-26       Impact factor: 4.742

4.  High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients.

Authors:  Xuebing Yan; Zezhi Shan; Leilei Yan; Qingchao Zhu; Liguo Liu; Bing Xu; Sihong Liu; Zhiming Jin; Yuping Gao
Journal:  Oncotarget       Date:  2016-04-12

Review 5.  Zinc finger proteins in cancer progression.

Authors:  Jayu Jen; Yi-Ching Wang
Journal:  J Biomed Sci       Date:  2016-07-13       Impact factor: 8.410

6.  miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.

Authors:  Run-Fa Bao; Yi-Jun Shu; Yun-Ping Hu; Xu-An Wang; Fei Zhang; Hai-Bin Liang; Yuan-Yuan Ye; Huai-Feng Li; Shan-Shan Xiang; Hao Weng; Yang Cao; Xiang-Song Wu; Mao-Lan Li; Wen-Guang Wu; Yi-Jian Zhang; Lin Jiang; Qian Dong; Ying-Bin Liu
Journal:  Oncotarget       Date:  2016-04-19

7.  PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78.

Authors:  Chiharu Moriya; Hiroaki Taniguchi; Satoru Nagatoishi; Hisayoshi Igarashi; Kouhei Tsumoto; Kohzoh Imai
Journal:  Cancer Sci       Date:  2017-12-28       Impact factor: 6.716

8.  Zinc finger protein X-linked promotes expansion of EpCAM+ cancer stem-like cells in hepatocellular carcinoma.

Authors:  Chao Wang; Si-Yuan Fu; Ming-da Wang; Wen-Bo Yu; Qin-Shu Cui; Hong-Ru Wang; Hai Huang; Wei Dong; Wei-Wei Zhang; Peng-Peng Li; Chuan Lin; Ze-Ya Pan; Yuan Yang; Meng-Chao Wu; Wei-Ping Zhou
Journal:  Mol Oncol       Date:  2017-03-29       Impact factor: 6.603

Review 9.  Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.

Authors:  Aarti Sharma; Kiran Lata Sharma; Annapurna Gupta; Alka Yadav; Ashok Kumar
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

10.  The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR.

Authors:  Shuai Zhao; Yang Cao; Shi-Bo Liu; Xu-An Wang; Run-Fa Bao; Yi-Jun Shu; Yun-Ping Hu; Yi-Jian Zhang; Lin Jiang; Fei Zhang; Hai-Bin Liang; Huai-Feng Li; Qiang Ma; Yi Xu; Zheng Wang; Yi-Chi Zhang; Lei Chen; Jian Zhou; Ying-Bin Liu
Journal:  J Exp Clin Cancer Res       Date:  2016-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.